Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F22F6DF0.svg?ark=w1%2F20260515%2FF22F6DF0)](https://nobleid.org/work/w1/20260515/F22F6DF0)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors